Gallimore A - Search Results

1

The impact of regulatory T cells on carcinogen-induced sarcogenesis.

Betts G, Twohig J, Van den Broek M, Sierro S, Godkin A, Gallimore A. Betts G, et al. Among authors: gallimore a. Br J Cancer. 2007 Jun 18;96(12):1849-54. doi: 10.1038/sj.bjc.6603824. Epub 2007 Jun 12. Br J Cancer. 2007. PMID: 17565340 Free PMC article.

2

Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.

Gallimore A, Glithero A, Godkin A, Tissot AC, Plückthun A, Elliott T, Hengartner H, Zinkernagel R. Gallimore A, et al. J Exp Med. 1998 May 4;187(9):1383-93. doi: 10.1084/jem.187.9.1383. J Exp Med. 1998. PMID: 9565631 Free PMC article.

3

The proteasome inhibitor lactacystin prevents the generation of an endoplasmic reticulum leader-derived T cell epitope.

Gallimore A, Schwarz K, van den Broek M, Hengartner H, Groettrup M. Gallimore A, et al. Mol Immunol. 1998 Jul;35(10):581-91. doi: 10.1016/s0161-5890(98)00053-4. Mol Immunol. 1998. PMID: 9823757

4

Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment.

Leung RK, Thomson K, Gallimore A, Jones E, Van den Broek M, Sierro S, Alsheikhly AR, McMichael A, Rahemtulla A. Leung RK, et al. Among authors: gallimore a. Nat Immunol. 2001 Dec;2(12):1167-73. doi: 10.1038/ni733. Nat Immunol. 2001. PMID: 11694883

5

Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression.

Probst HC, Tschannen K, Gallimore A, Martinic M, Basler M, Dumrese T, Jones E, van den Broek MF. Probst HC, et al. Among authors: gallimore a. J Immunol. 2003 Nov 15;171(10):5415-22. doi: 10.4049/jimmunol.171.10.5415. J Immunol. 2003. PMID: 14607945

6

Regulating the immune response to tumours.

Betts GJ, Clarke SL, Richards HE, Godkin AJ, Gallimore AM. Betts GJ, et al. Adv Drug Deliv Rev. 2006 Oct 1;58(8):948-61. doi: 10.1016/j.addr.2006.05.006. Epub 2006 Aug 17. Adv Drug Deliv Rev. 2006. PMID: 17070961 Review.

7

T-cell costimulation.

Wise MP, Gallimore A, Godkin A. Wise MP, et al. Among authors: gallimore a. N Engl J Med. 2006 Dec 14;355(24):2594-5; author reply 2595. doi: 10.1056/NEJMc062767. N Engl J Med. 2006. PMID: 17167146 No abstract available.

8

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.

Clarke SL, Betts GJ, Plant A, Wright KL, El-Shanawany TM, Harrop R, Torkington J, Rees BI, Williams GT, Gallimore AM, Godkin AJ. Clarke SL, et al. Among authors: gallimore am. PLoS One. 2006 Dec 27;1(1):e129. doi: 10.1371/journal.pone.0000129. PLoS One. 2006. PMID: 17205133 Free PMC article.

9

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity.

Simon AK, Jones E, Richards H, Wright K, Betts G, Godkin A, Screaton G, Gallimore A. Simon AK, et al. Among authors: gallimore a. Eur J Immunol. 2007 Mar;37(3):758-67. doi: 10.1002/eji.200636593. Eur J Immunol. 2007. PMID: 17294404 Free PMC article.

10

Potent T cell agonism mediated by a very rapid TCR/pMHC interaction.

Boulter JM, Schmitz N, Sewell AK, Godkin AJ, Bachmann MF, Gallimore AM. Boulter JM, et al. Eur J Immunol. 2007 Mar;37(3):798-806. doi: 10.1002/eji.200636743. Eur J Immunol. 2007. PMID: 17295390 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters